Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus

Detalhes bibliográficos
Autor(a) principal: Manuelle Maria Pereira Natividade
Data de Publicação: 2016
Outros Autores: Caroline Pereira Domingueti, Ana Paula Salles Moura Fernandes, Rodrigo Bastos Fóscolo, Janice Sepúlveda Reis, Luci Maria SantAna Dusse, Camila Stefanie Fonseca de Oliveira, João Paulo Amaral Haddad, Lara Carvalho Godoi, Karina Braga Gomes Borges, Henrique Pimenta Barroso Magalhães
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFMG
Texto Completo: https://doi.org/10.9734/BJMMR/2016/23476
http://hdl.handle.net/1843/40274
Resumo: CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico
id UFMG_9d7e46f2d0db7d897844705bd2ec3dce
oai_identifier_str oai:repositorio.ufmg.br:1843/40274
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling 2022-03-21T16:05:09Z2022-03-21T16:05:09Z2016153114https://doi.org/10.9734/BJMMR/2016/234762231-0614http://hdl.handle.net/1843/40274CNPq - Conselho Nacional de Desenvolvimento Científico e TecnológicoCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorIntroduction: It is known that laboratorial tests (urinary albumin excretion and glomerular filtration rate), routinely used for nephropathy diagnosis in type 1 diabetes (T1DM), have limitations that justify the evaluation of new renal biomarkers. This study assessed the performance of cystatin C, alkaline phosphatase (AP) and gamma-glutamyl transferase (GGT) for nephropathy diagnosis in T1DM patients. The reduction of economic cost and increase in sensibility and specificity from correct biochemical diagnosis of diabetic nephropathy is an important objective of this work. Methods: Cystatin C, AP and GGT were determined in plasma and urine of healthy individuals (N=35) and T1DM patients with (N=45) and without nephropathy (N=80). Results: The plasma levels of cystatin C, AP and GGT, as well as urinary levels of cystatin C and AP were able to differentiate diabetic patients with and without nephropathy. Plasma cystatin C better followed the progression of albuminuria. Cystatin C and AP discriminated the onset of nephropathy in T1DM patients better than creatinine. AP plasma/urine ratio progressively increased from the controls to the diabetic patients without and with nephropathy. Conclusion: The plasma levels of cystatin C and AP may be useful, with the classical markers of renal function, for nephropathy diagnosis and monitoring in T1DM patients.engUniversidade Federal de Minas GeraisUFMGBrasilFAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICASICB - DEPARTAMENTO DE MICROBIOLOGIABritish Journal of Medicine and Medical ResearchNefropatias diabéticasDiabetes mellitusCistatina CFosfatase alcalinaGama-glutamiltransferaseDiabetic nephropathyCystatin CAlkaline phosphataseGamma-glutamyl transferasePerformance of new biomarkers of nephropathy in patients with type 1 diabetes mellitusinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://www.journaljammr.com/index.php/JAMMR/article/view/10278Manuelle Maria Pereira NatividadeCaroline Pereira DominguetiAna Paula Salles Moura FernandesRodrigo Bastos FóscoloJanice Sepúlveda ReisLuci Maria SantAna DusseCamila Stefanie Fonseca de OliveiraJoão Paulo Amaral HaddadLara Carvalho GodoiKarina Braga Gomes BorgesHenrique Pimenta Barroso Magalhãesapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/40274/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALPerformance of new biomarkers of nephropathy inpatients withtype 1 Diabetes mellitus.pdfPerformance of new biomarkers of nephropathy inpatients withtype 1 Diabetes mellitus.pdfapplication/pdf318198https://repositorio.ufmg.br/bitstream/1843/40274/2/Performance%20of%20new%20biomarkers%20of%20nephropathy%20inpatients%20withtype%201%20Diabetes%20mellitus.pdf7ac73a388a0dd20a6a77ab89ea3113dcMD521843/402742022-03-21 13:05:09.628oai:repositorio.ufmg.br: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Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2022-03-21T16:05:09Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.pt_BR.fl_str_mv Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
title Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
spellingShingle Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
Manuelle Maria Pereira Natividade
Diabetic nephropathy
Cystatin C
Alkaline phosphatase
Gamma-glutamyl transferase
Nefropatias diabéticas
Diabetes mellitus
Cistatina C
Fosfatase alcalina
Gama-glutamiltransferase
title_short Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
title_full Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
title_fullStr Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
title_full_unstemmed Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
title_sort Performance of new biomarkers of nephropathy in patients with type 1 diabetes mellitus
author Manuelle Maria Pereira Natividade
author_facet Manuelle Maria Pereira Natividade
Caroline Pereira Domingueti
Ana Paula Salles Moura Fernandes
Rodrigo Bastos Fóscolo
Janice Sepúlveda Reis
Luci Maria SantAna Dusse
Camila Stefanie Fonseca de Oliveira
João Paulo Amaral Haddad
Lara Carvalho Godoi
Karina Braga Gomes Borges
Henrique Pimenta Barroso Magalhães
author_role author
author2 Caroline Pereira Domingueti
Ana Paula Salles Moura Fernandes
Rodrigo Bastos Fóscolo
Janice Sepúlveda Reis
Luci Maria SantAna Dusse
Camila Stefanie Fonseca de Oliveira
João Paulo Amaral Haddad
Lara Carvalho Godoi
Karina Braga Gomes Borges
Henrique Pimenta Barroso Magalhães
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Manuelle Maria Pereira Natividade
Caroline Pereira Domingueti
Ana Paula Salles Moura Fernandes
Rodrigo Bastos Fóscolo
Janice Sepúlveda Reis
Luci Maria SantAna Dusse
Camila Stefanie Fonseca de Oliveira
João Paulo Amaral Haddad
Lara Carvalho Godoi
Karina Braga Gomes Borges
Henrique Pimenta Barroso Magalhães
dc.subject.por.fl_str_mv Diabetic nephropathy
Cystatin C
Alkaline phosphatase
Gamma-glutamyl transferase
topic Diabetic nephropathy
Cystatin C
Alkaline phosphatase
Gamma-glutamyl transferase
Nefropatias diabéticas
Diabetes mellitus
Cistatina C
Fosfatase alcalina
Gama-glutamiltransferase
dc.subject.other.pt_BR.fl_str_mv Nefropatias diabéticas
Diabetes mellitus
Cistatina C
Fosfatase alcalina
Gama-glutamiltransferase
description CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2022-03-21T16:05:09Z
dc.date.available.fl_str_mv 2022-03-21T16:05:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1843/40274
dc.identifier.doi.pt_BR.fl_str_mv https://doi.org/10.9734/BJMMR/2016/23476
dc.identifier.issn.pt_BR.fl_str_mv 2231-0614
url https://doi.org/10.9734/BJMMR/2016/23476
http://hdl.handle.net/1843/40274
identifier_str_mv 2231-0614
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv British Journal of Medicine and Medical Research
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.publisher.initials.fl_str_mv UFMG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS
ICB - DEPARTAMENTO DE MICROBIOLOGIA
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
bitstream.url.fl_str_mv https://repositorio.ufmg.br/bitstream/1843/40274/1/License.txt
https://repositorio.ufmg.br/bitstream/1843/40274/2/Performance%20of%20new%20biomarkers%20of%20nephropathy%20inpatients%20withtype%201%20Diabetes%20mellitus.pdf
bitstream.checksum.fl_str_mv fa505098d172de0bc8864fc1287ffe22
7ac73a388a0dd20a6a77ab89ea3113dc
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv
_version_ 1801676887434461184